2025 Annual General Meeting Chair Address & Presentation
Filed with ASX · · 29 pages · English
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings CallGenetic Signatures Limited [ASX:GSS] (“GSS” or the “Company”) advises in accordance with ASX Listing Rule 3.13.3, a copy of the address by Chair, Caroline Waldron and slides to be presented at today’s Annual General Meeting are attached. – END – Announcement authorised for release by the Board of Genetic Signatures Limited. For further information, see our website (www.geneticsignatures.com) or co
Genetic Signatures Ltd. on 6ix
In the deck
Story so far
Earlier from Genetic Signatures
- FY25 Market Update
- FY25 Results Release
- FY25 Appendix 4E and Annual Report
- Strategic Partnership with Tecan and Repado
- 1H FY25 Market Update
Later from Genetic Signatures
- Leadership Change at Genetic Signatures Limited
- Quarterly Activities/Appendix 4C Cash Flow Report
- Genetic Signatures Appoints Maria Halasz as CEO
- GSS Appoints Anne Lockwood as Interim Managing Director
- 1H FY26 Appendix 4D and Half Year Report
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures